Table 1 Clinical characteristics of severely-symptomatic COVID-19 patients, mildly-symptomatic COVID-19 patients and non SARS-CoV-2 infected control subjects
From: Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy
Whole cohort (N = 361) | Non SARS-CoV-2 infected Control (N = 206) | Mildly symptomatic COVID-19 (n = 52) | Severely Symptomatic COVID-19 (n = 103) | P-value | |
|---|---|---|---|---|---|
Age, years median [IQR] | 66.00 [54.00–78.00] | 67.00 [57.00–77.00] | 57.50 [51.00–86.05] | 66.70 [56.10–77.40] | 0.649 ǂ |
Male N(%) | 243 (67%) | 142 (69%) | 31 (60%) | 70 (68%) | 0.435† |
CV disease a N(%) | 54 (15%) | 31 (15%) | 11 (21%) | 12 (12%) | 0.293† |
At least 1 comorbidity b N(%) | 181 (50%) | 95 (46%) | 23 (44%) | 63 (61%) | 0.03† |
Obesity N (%) | 67 (19%) | 42 (20%) | 5 (10%) | 20 (19%) | 0.196† |
Diabetes N (%) | 61 (17%) | 31 (15%) | 11 (21%) | 19 (18%) | 0.510† |
Hypertension N (%) | 140 (39%) | 75 (36%) | 13 (25%) | 52 (51%) | 0.005† |
vitamin D deficiency (25OHD ≤20 ng/mL) N(%) | 127 (35%) | 57 (28%) | 6 (12%) | 64 (62%) | < 0.0001† |
25OHD ng/mL mean (SD) | 24.0 (10.6) | 25.4 (9.4) | 30.3 (8.4) | 18.2 (11.4) | < 0.0001‡ |